Reuters logo
2 个月前
BRIEF-Shire plc says U.S. FDA approves Mydayis
2017年6月20日 / 晚上10点56分 / 2 个月前

BRIEF-Shire plc says U.S. FDA approves Mydayis

June 20 (Reuters) - Shire Plc

* U.S. FDA approves Mydayis (mixed salts of a single-entity amphetamine product) - a new once-daily option for ADHD symptom control in patients 13 years and older

* Expects to make Mydayis commercially available in United States in Q3 of 2017

* Shire plc says expects to make Mydayis commercially available in United States in Q3 of 2017

Source text for Eikon:

Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below